Clinical Trial Update: A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating Ivonescimab in combination with Cadonilimab and chemotherapy for extensive-stage small cell lung cancer; the trial is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Cadonilimab
• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: SCLC, Extensive Stage | Phase 2 | Status: NOT_YET_RECRUITING